Malignant tumours and immunity.
D000912:Antibodies, Neoplasm; D000937:Antigen-Antibody Reactions; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents / Q000494:pharmacology; D002051:Burkitt Lymphoma / Q000276:immunology; D002477:Cells / Q000187:drug effects; D002822:Choriocarcinoma / Q000276:immunology; D005260:Female; D005916:Globulins / Q000627:therapeutic use; D006801:Humans; D007109:Immunity; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes; D007167:Immunotherapy; D002479:Inclusion Bodies / Q000276:immunology; D007938:Leukemia / Q000276:immunology; D009101:Multiple Myeloma / Q000276:immunology; D009369:Neoplasms / Q000150:complications / Q000201:enzymology / Q000209:etiology / Q000276:immunology* / Q000378:metabolism / Q000628:therapy; D011247:Pregnancy; D012194:RNA-Directed DNA Polymerase / Q000378:metabolism; D014020:Tissue Extracts / Q000627:therapeutic use; D009396:Wilms Tumor / Q000276:immunology
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D005916:Globulins; D014020:Tissue Extracts; D012194:RNA-Directed DNA Polymerase